Treatment of murine pulmonary blastomycosis with SCH 39304, a new triazole antifungal agent.
SCH 39304, a broad-spectrum azole derivative, was evaluated in an experimental mouse model of blastomycosis pneumonia. Five days after being inoculated with Blastomyces dermatitidis, infected mice were treated with either oral SCH 39304, fluconazole, or intraperitoneal amphotericin B. A dose respons...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1990
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171713/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2360825/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.5.896 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|